ABVC vs NDAQ · rev $796.0K vs P/E 41, rev $2.53B
ABVC Biopharma Inc (ABVC) versus Nasdaq Inc (NDAQ) — a side-by-side from cached financials, not a winner call.
ABVC Biopharma Inc (ABVC) is a biotechnology company listed on NASDAQ.
Nasdaq Inc (NDAQ) is a financial data & stock exchanges company listed on US.
Latest reported ABVC revenue for 2025-09-30 was $796.0K. Net income was -$1.3M. ABVC currently screens at market cap $35.9M.
Latest reported NDAQ revenue for 2026-06-30 was $2.53B. Net income was $507.0M. Revenue was up 18.5% from 2026-03-31 to 2026-06-30. NDAQ currently screens at market cap $51.71B and trailing P/E 40.8.
ABVC currently screens at market cap $35.9M. NDAQ currently screens at market cap $51.71B and trailing P/E 40.8.
Not investment advice. Open the ABVC and NDAQ stock pages for the full models.
Not investment advice.